Myotonic dystrophies are rare autosomal dominant neuromuscular disorders. Multinational patient registries are an important resource that aims to unite clinical and genetic patients’ data in order to help widen our knowledge about the natural history of the disease, to establish diagnostic and care standards, and to facilitate recruitment of patients, eligible for clinical trials for new therapeutic strategies. The international network TREAT-NMD focuses on the clinical and preclinical development, that industry, clinicians and scientists need in order to bring novel therapeutic approaches, and on establishing best-practice care for neuromuscular patients worldwide. The Bulgarian patient registry for myotonic dystrophies works in collaboration with TREAT-NMD.
The aim of our study is to investigate the disease in the Bulgarian population and to compare the results with the data in the literature. This study can be used further to facilitate the recruitment of eligible patients for future clinical trials. The following article is focused on the onset of the disease, the inheritance and the respiratory and cardiac complications.
Key words: myotonic dystrophy, national patient registry, cardiac and respiratory complications
Topic: MEDICINE